(Q33938580)

English

Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Vasankari T

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ahotupa M

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Toikka J

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Mikkola J

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Irjala K

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pasanen P

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Neuvonen K

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Raitakari O

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Viikari J

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

155

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

403-412

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

In Vivo Low Density Lipoprotein Oxidation Relates to Coronary Reactivity in Young Men

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Minimally modified low density lipoprotein is biologically active in vivo in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

High affinity binding of oxidized LDL to mouse lectin-like oxidized LDL receptor (LOX-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Unique repetitive sequence and unexpected regulation of expression of rat endothelial receptor for oxidized low-density lipoprotein (LOX-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Is oxidized low‐density lipoprotein present in vivo?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Large-artery elastic properties in young men : relationships to serum lipoproteins and oxidized low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Familial aggregation of LDL oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Reduced oxidized LDL levels after a 10-month exercise program

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Reduced mildly oxidized LDL in young female athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Effects of Acute Prolonged Exercise on Serum and LDL Oxidation and Antioxidant Defences

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Lower patients' cholesterol now

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900573-6

7 January 2021

Identifiers

10.1016/S0021-9150(00)00573-6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33938580&oldid=1957217488"